Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 39.59 USD 1.67% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Veracyte Inc?
Write Note

Relative Value

The Relative Value of one VCYT stock under the Base Case scenario is 23.96 USD. Compared to the current market price of 39.59 USD, Veracyte Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VCYT Relative Value
Base Case
23.96 USD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
50
vs Industry
64
Median 3Y
5.8
Median 5Y
7.3
Industry
7.7
Forward
6.7
vs History
vs Industry
Median 3Y
-38
Median 5Y
-47.7
Industry
22.7
Forward
216
vs History
28
vs Industry
3
Median 3Y
44.2
Median 5Y
-63.1
Industry
21.6
vs History
23
vs Industry
2
Median 3Y
43.9
Median 5Y
-57.1
Industry
25.2
vs History
41
vs Industry
50
Median 3Y
1.7
Median 5Y
2.1
Industry
2.5
vs History
50
vs Industry
57
Median 3Y
5.2
Median 5Y
6.7
Industry
7.7
Forward
6.1
vs History
52
vs Industry
49
Median 3Y
7.8
Median 5Y
10.2
Industry
9
vs History
15
vs Industry
1
Median 3Y
-45.3
Median 5Y
-59
Industry
4.2
Forward
64.1
vs History
4
vs Industry
Median 3Y
-42.6
Median 5Y
-49.3
Industry
4.1
Forward
-777.5
vs History
26
vs Industry
4
Median 3Y
38.6
Median 5Y
-57.6
Industry
5.7
vs History
20
vs Industry
3
Median 3Y
38
Median 5Y
-74.5
Industry
3.6
vs History
41
vs Industry
51
Median 3Y
1.7
Median 5Y
2.2
Industry
4.6

Multiples Across Competitors

VCYT Competitors Multiples
Veracyte Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Veracyte Inc
NASDAQ:VCYT
3B USD 7.2 -331 83.5 299.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
US
Veracyte Inc
NASDAQ:VCYT
Average P/E: 208.3
Negative Multiple: -331
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Veracyte Inc
NASDAQ:VCYT
Average EV/EBITDA: 26.7
83.5
896%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
Veracyte Inc
NASDAQ:VCYT
Average EV/EBIT: 62
299.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top